Obesity and diabetes are two of the most prevalent chronic health conditions in the world, and the relationship between them is complex and far-reaching. In this article, we will explore the pathophysiology of the relationship between obesity and diabetes, and look at how treatments can be combined to improve outcomes …
Read More »Exploring the Microbiome’s Role in Obesity and Diabetes
The microbiome, the complex ecosystem of microorganisms that live in and on the human body, has been linked to a variety of health conditions, including obesity and diabetes. In recent years, researchers have been exploring the microbiome’s role in these conditions, in order to better understand the connection between them. …
Read More »Exploring the Role of Anti-Obesity Medications in Type 2 Diabetes
The prevalence of obesity and type 2 diabetes is on the rise, and healthcare professionals are searching for innovative ways to combat these conditions. Anti-obesity medications are a promising tool for managing these chronic diseases. This article will explore the role of anti-obesity medications in type 2 diabetes and discuss …
Read More »The Link Between Obesity and Insulin Resistance: Mechanisms and Treatment
Obesity and insulin resistance are two of the most common health problems worldwide. Both of these conditions have serious implications for health and can lead to a wide variety of other medical issues. This article will discuss the link between obesity and insulin resistance, the mechanisms underlying this link, and …
Read More »Metabolic Implications of Bariatric Surgery in Type 2 Diabetes Patients
Bariatric surgery has become a well-established treatment option for individuals suffering from obesity and its associated comorbidities, including type 2 diabetes. This article will discuss the metabolic implications of bariatric surgery in type 2 diabetes patients, including the metabolic benefits and postoperative care. Overview of Bariatric Surgery Bariatric surgery is …
Read More »Liraglutide’s Effects in Overweight and Obese Adults at High CV Risk
Liraglutide to positively effect decrease in visceral fat in overweight and obese patients without history of type 2 diabetes. Critical drivers of adverse cardiometabolic outcomes in obese patients are visceral and ectopic fat, which is wrapped around the abdominal organs in the body. This type of fat can lead to …
Read More »Diabetes and CVD Mortality Linked to Weight Loss and Regain
Data analysis suggests that weight changes during weight loss attempts may raise the risk of cardiovascular disease and mortality in people with type 2 diabetes.
Read More »Can a Calorie-Restricted Diet Improve Long-Term Progressive Kidney Function Decline?
Studies have found that there may be a benefit in implementing a calorie-restricted diet in patients with type 2 diabetes to improve glomerular hyperfiltration.
Read More »Identifying Gestational Diabetes and its Causes
Gestational diabetes mellitus (GDM) is becoming more common, which calls for a deeper understanding of this disorder.
Read More »Novel Monoclonal Antibody Linked to Increased Muscle Development and Reduction in Body Fat
A new study reveals that bimagrumab can have metabolic improvement for those suffering from obesity and type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.